NMS5020 - Nuclear medicine and radiopharmacy 3

Leader: Associate Professor Marilyn Baird

Offered

Clayton Summer semester A 2008 (Off-campus)

Synopsis

This unit deals with nuclear medicine and radiopharmacy rationale/methods. It utilises knowledge and understanding gained in NMS4021 and NMS5000 to develop greater understanding of complex nuclear medicine techniques. More advanced applications in oncology, infection, paediatrics, PET, hybrid imaging and radionuclide therapy are used to provide learning context. Other imaging modalities, such as DEXA, Sonography, CT and MRI are also discussed. The unit content is given structure and direction by addressing specific learning objectives related to:

1. Advanced radiopharmacy;
2. Complex imaging and Radionuclide Therapy;
3. Complimentary studies;
4. Complex image processing.

Objectives

On successful completion of this unit students will be able to demonstrate and communicate a broad and critical conceptual and practical understanding of:

1. Advanced radiopharmacy, in relation to:
• Drug development, pre-clinical imaging and pharmacology;
• Dosimetry;
• PET radiopharmacy, radiation safety and facility design.
2. Complex imaging and radionuclide therapy procedures, including patient preparation, positioning and care, in relation to:
• PET imaging;
• Paediatric studies;
• Oncology;
• CNS imaging;
• Radionuclide therapy;
• PET/CT applications;
• SPECT/CT applications;
3. Complementary studies in Medical Radiations, in relation to:
• CT for Nuclear Medicine;
• US for Nuclear Medicine;
• MRI for Nuclear Medicine;
• DEXA.
4. Complex image processing and display, in particular:
• Raw data analysis;

• Image quality control;
• Image interpretation and critique.

Assessment

Two clinical action plans of approx 1500 wds and accompanying comparative reports of approx 1500 wds 40%
One 180 minute end of semester written examination 60%

Prerequisites

NMS5000, RTS5010

Co-requisites

RTS5022